Nippon India Nifty Pharma ETF
PHARMABEES
- Price
- ₹26.37
- 1D
- -0.60%
- 1W
- -0.70%
- 1Y
- +17.06%
Day low ₹26.30Day high ₹26.94
- Tracks
- Nifty Pharma
- iNAV
- ₹26.51
- NAV, 16 Oct 2026
- ₹26.34
- Premium / discount
- -0.52%
- 52W range
- ₹21.69 – ₹28.58
- 3Y
- +19.84%
- 5Y
- +12.41%
- Expense ratio
- 0.21%
- AUM
- ₹1,610 Cr
- Liquidity
- High
- AMC
- Nippon India Mutual Fund
- Listed
- 2021
Tax on gains
- Sold within 1 year
- 20% of the gain
- Sold after 1 year
- 12.5% of the gain above ₹1.25 lakh
Rules for FY 2026-27. All rules
About this ETF
This ETF tracks the Nifty Pharma index, which holds India's top 20 pharmaceutical companies. India is one of the world's largest drug exporters, and this index covers that entire industry.
Top 10 holdings
- Sun Pharmaceutical Industries23.79%
- Divis Laboratories9.10%
- Torrent Pharmaceuticals7.90%
- Lupin6.09%
- Dr Reddys Laboratories5.95%
- Cipla5.64%
- Zydus Lifesciences5.09%
- Mankind Pharma4.83%
- Aurobindo Pharma4.54%
- Alkem Laboratories3.68%